Updated: Thousand Oaks biotech firm emerges from stealth with $135M in funding

Editor's note: This story was updated on Feb. 23 to include more info about the company's lead treatment. Latigo Biotherapeutics, a Thousand Oaks-based biotech firm that was originally founded by Westlake Village BioPartners, emerged from stealth mode on Feb. 14, announcing $135 million in Series A financing. Latigo is a clinical-stage biotechnology company looking to

Related Keywords

Beth Seidenberg ,Nancy Stagliano ,Latigo Biotherapeutics ,Sean Harper ,Los Angeles ,Desmond Padhi , ,Jorge Mercado Friday ,Thousand Oaks Based ,Westlake Village Biopartners ,Foresite Capital ,San Francisco Based Neuron ,Village Biopartners ,Conejo Valley ,Thousand Oaks ,Health Care Amp Life Science ,Latest News ,Left ,Technology ,